Onconova drugs itself with $50m

Aug 16, 2012 • Global Corporate Venturing

Onconova Therapeutics, a US-based anti-cancer drugs developer backed in India-based peer Cadila Healthcare, has raised $50m, according to a regulatory filing.

News provider Philadelphia Business Journal reports that the developer raised $26.4m in a two-part raise earlier in the year.

Investors currently represented on the Onconova’s board include Cadila Healthcare, and venture capital firms ICICI Ventures (part of Indian financial services group ICICI), Starec and Naftali, Tinicum Partners and Mehta Partners.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

FUNDING ROUND DATA

Which corporates are backing which startups? Search our corporate deal database.

RISING STARS

Introducing the GCV Rising Stars 2024

EMERGING LEADERS

Introducing the GCV Emerging Leaders 2024

Events

GCV Institute: Landing the Value of Corporate Venturing

May 6 -
May 9, 2024
Online

Find out more All events

Events

Webinar: CVCs and the art of the follow-on

May 8, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

May 21 -
May 22, 2024
Online

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

About us

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.